Literature DB >> 30665615

Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).

Christine H Holschneider1, Daniel G Petereit2, Christina Chu3, I-Chow Hsu4, Yevgeniya J Ioffe5, Ann H Klopp6, Bhavana Pothuri7, Lee-May Chen8, Catheryn Yashar9.   

Abstract

Brachytherapy is well-established as an integral component in the standard of care for treatment of patients receiving primary radiotherapy for cervical cancer. A decline in brachytherapy has been associated with negative impacts on survival in the era of modern EBRT techniques. Conformal external beam therapies such intensity modulated radiation therapy (IMRT) or stereotactic body radiation therapy (SBRT) should not be used as alternatives to brachytherapy in patients undergoing primary curative-intent radiation therapy for cervical cancer. Computed tomography or magnetic resonance image-guided adaptive brachytherapy is evolving as the preferred brachytherapy method. With careful care coordination EBRT and brachytherapy can be successfully delivered at different treatment centers without compromising treatment time and outcome in areas where access to brachytherapy maybe limited.
Copyright © 2018 Elsevier Inc., American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Cervical cancer; IMRT; Primary chemoradiation; SBRT

Mesh:

Year:  2019        PMID: 30665615     DOI: 10.1016/j.ygyno.2018.10.016

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.

Authors:  Fumiaki Isohashi; Yuichi Akino; Yuri Matsumoto; Osamu Suzuki; Yuji Seo; Keisuke Tamari; Iori Sumida; Kenjiro Sawada; Yutaka Ueda; Eiji Kobayashi; Takuji Tomimatsu; Erina Nakanishi; Takahisa Nishi; Tadashi Kimura; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

2.  Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.

Authors:  David Boyce-Fappiano; Kevin A Nguyen; Olsi Gjyshi; Gohar Manzar; Chike O Abana; Ann H Klopp; Mitchell Kamrava; Peter F Orio; Nikhil G Thaker; Firas Mourtada; Puja Venkat; Albert J Chang
Journal:  JCO Oncol Pract       Date:  2021-09-22

3.  Disparities Among Cervical Cancer Patients Receiving Brachytherapy.

Authors:  Shaina F Bruce; Tanvi V Joshi; Inna Chervoneva; Misung Yi; Sudeshna Chatterjee-Paer; Elizabeth R Burton; Mitchell I Edelson; Joel I Sorosky; Mark S Shahin
Journal:  Obstet Gynecol       Date:  2019-09       Impact factor: 7.623

4.  Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment.

Authors:  Michael D Schad; Joanna Moore; Fabian Camacho; Roger T Anderson; Leigh A Cantrell; Timothy N Showalter
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  Polish Brachytherapy Society - Presidential opening: Chasing Brachytherapy.

Authors:  Piotr Wojcieszek
Journal:  J Contemp Brachytherapy       Date:  2019-10-30

6.  Brachytherapy utilization for cervical cancer in Western United States border counties: seeking to understand referral patterns for outcome improvement.

Authors:  Christine H Feng; Corinne McDaniels-Davidson; Maria Elena Martinez; Jesse Nodora; Arno J Mundt; Jyoti S Mayadev
Journal:  J Contemp Brachytherapy       Date:  2021-12-30

7.  Evaluation of the impact of EMBRACE II protocol in Spanish centers, with a large cohort of patients using a ranking index.

Authors:  Jose Chimeno; Naiara Fuentemilla; Paula Monasor; Francisco Celada; Elena Villafranca; Sílvia Rodriguez; María José Pérez-Calatayud; Santiago Pellejero; Jose Pérez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2021-12-30

8.  Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy.

Authors:  Nuria Carrasco; Jose Chimeno; Mar Adrià-Mora; María José Pérez-Calatayud; Blanca Ibáñez; Vicente Carmona; Francisco Celada; Jose Gimeno; Françoise Lliso; José Pérez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2020-04-17

Review 9.  The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry.

Authors:  Tibor Major; Georgina Fröhlich; Péter Ágoston; Csaba Polgár; Zoltán Takácsi-Nagy
Journal:  Strahlenther Onkol       Date:  2021-11-01       Impact factor: 3.621

10.  Populations at high risk of cervical cancer in Guangxi Province: Findings from two screening projects in a minority area of South China.

Authors:  Huaxiang Lu; Haoyu He; Jian Qin; Mingjian Chen; Qiumei Liu; Min Li; Yongsheng Huang; Anxiang Wei; Shuzhen Liu; Min Xu; Zhiyong Zhang
Journal:  J Med Screen       Date:  2021-10-25       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.